Rapamycin is an effective inhibitor of human renal cancer metastasis11See Editorial by Sukhatme and Strom, p. 1160.

Fu L. Luan(Cornell University), Manikkam Suthanthiran(NewYork–Presbyterian Hospital), Vijay K. Sharma(Cornell University), W. James Chon(NewYork–Presbyterian Hospital), Ruchuang Ding(NewYork–Presbyterian Hospital), Milagros Lagman(NewYork–Presbyterian Hospital)
Kidney International
March 1, 2003
Cited by 208


Related Papers